Micron Faces Wafer Constraints Capping Upside

The Seeking Alpha contributor reports that HBM consumes roughly three times the wafer area of standard DDR5, and that HBM4 will widen that gap. The article attributes to Goldman Sachs an estimate that Micron accounted for 51% of S&P 500 EPS revisions since the Iran war began. The piece reports the Street is modeling 605% FY26 EPS growth for Micron. The article also notes the launch of the 245TB Micron 6600 ION SSD, which the author says reduces required rack count by 82% versus HDDs. Finally, the contributor lays out a valuation "floor-to-ceiling" framework: a $600 floor, a $750 base case, and a ceiling conditional on a potential 2028 shortage, with a cited Street-high target of $1,000.

Industry-pattern observations: wafer-area intensity is a measurable constraint for memory suppliers. When a product like HBM requires substantially more wafer area per unit of capacity than commodity DRAM, overall industry output of HBM-class devices is limited by total fab wafer starts and capacity, not just demand-side metrics. High-density SSDs such as the 245TB 6600 ION change storage density math for data centers by reducing rack footprint and power per terabyte, a factor operators consider when optimizing TCO.

Industry observers note that supply-side ceilings in silicon-limited segments can shift market dynamics from demand volatility to capacity allocation battles. For practitioners tracking AI infrastructure, memory supply tightness (HBM/HBM4) matters because it can constrain accelerator memory availability and raise component pricing. At the same time, higher-density SSDs affect data-center architecture tradeoffs by lowering physical footprint and potentially reducing network and power overhead per TB.

Indicators worth following include fab wafer starts and utilization for HBM-capable processes, adoption rate of HBM4, enterprise uptake and benchmarks for the 245TB 6600 ION SSD, and near-term EPS revision activity tracked by sell-side firms. The Seeking Alpha contributor provides a scenario-based valuation; observers will watch whether market EPS revisions and actual supply trends converge toward the contributor's 2028 shortage scenario or toward a more supply-abundant outcome.